CXCL12 and B-cell chronic lymphocytic leukemia: Comparable to ibrutinib, SpiD3 reduced OSU-CLL cell migration toward CXCL-12, a chemokine secreted by bone marrow stromal cells (ref. 31; Supplementary Fig. S4A).